Yihua Bei

MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27.

MicroRNAs in diabetic cardiomyopathy and clinical perspectives.

Desregulated microRNAs in aging-related heart failure.

MicroRNA-221 is required for proliferation of mouse embryonic stem cells via P57 targeting.

Cardiac telocytes and fibroblasts in primary culture: different morphologies and immunophenotypes.

Telocytes in regenerative medicine.

Cardiac telocytes are double positive for CD34/PDGFR-α.

Exercise as a platform for pharmacotherapy development in cardiac diseases.

Exercise for the heart: signaling pathways.

Non-coding RNAs in cardiac regeneration.

miR-382 targeting PTEN-Akt axis promotes liver regeneration.

miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.

Telocytes in cardiac regeneration and repair.

RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.

miR-19b attenuates H2O2-induced apoptosis in rat H9C2 cardiomyocytes via targeting PTEN.

Telocytes in exercise-induced cardiac growth.

miR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2.

miR-149 controls non-alcoholic fatty liver by targeting FGF-21.

Therapeutic inhibition of phospholipase D1 suppresses hepatocellular carcinoma.

Telocytes in Cardiac Protection.

Crucial Role of miR-433 in Regulating Cardiac Fibrosis.

Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice.

Decoding Telocytes.

Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure.

miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury.

Cardiac cell proliferation is not necessary for exercise-induced cardiac growth but required for its protection against ischaemia/reperfusion injury.

Long Non-Coding RNAs in Cardiac Remodeling.

MicroRNA Expression Signature in Human Calcific Aortic Valve Disease.

Exercise-induced circulating extracellular vesicles protect against cardiac ischemia-reperfusion injury.

Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats.

miR-29b contributes to multiple types of muscle atrophy.

Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients.

Therapeutic Inhibition of miR-4260 Suppresses Colorectal Cancer via Targeting MCC and SMAD4.

Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPARγ.

MicroRNAs in muscle wasting and cachexia induced by heart failure.

MicroRNA-222 Promotes the Proliferation of Pulmonary Arterial Smooth Muscle Cells by Targeting P27 and TIMP3.

Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases.

Circulating Exosomes in Cardiovascular Diseases.

Formation of New Cardiomyocytes in Exercise.

miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1.

MicroRNAs Mediate Beneficial Effects of Exercise in Heart.

Extracellular Vesicles in Cardiovascular Theranostics.

miR-21 suppression prevents cardiac alterations induced by d-galactose and doxorubicin.

Neonatal Rat Cardiomyocytes Isolation, Culture, and Determination of MicroRNAs' Effects in Proliferation.

Dynamic Regulation of Circulating microRNAs During Acute Exercise and Long-Term Exercise Training in Basketball Athletes.

miR-486 inhibits PM2.5-induced apoptosis and oxidative stress in human lung alveolar epithelial A549 cells.

Cardiovascular medicine in China: what can we do to achieve the Healthy China 2030 plan?

Noncoding RNAs in Cardiac Hypertrophy.

Circular RNAs as Novel Biomarkers for Cardiovascular Diseases.

Circular RNAs as Potential Theranostics in the Cardiovascular System.

Immunomodulation by Exosomes in Myocardial Infarction.

Advance for Cardiovascular Health in China.

Cardiac Progenitor Cell-Derived Extracellular Vesicles: a Rising Star for Cardiac Repair and Regeneration.

Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury.

Correction to: Exercise-induced circulating extracellular vesicles protect against cardiac ischemia-reperfusion injury.

Editorial: Gender Differences in Cardiovascular Diseases.

Long Noncoding RNA Cardiac Physiological Hypertrophy-Associated Regulator Induces Cardiac Physiological Hypertrophy and Promotes Functional Recovery After Myocardial Ischemia-Reperfusion Injury.

Erratum: Crucial Role of miR-433 in Regulating Cardiac Fibrosis: Erratum.

Animal exercise studies in cardiovascular research: Current knowledge and optimal design-A position paper of the Committee on Cardiac Rehabilitation, Chinese Medical Doctors' Association.

Protocol of a Prospective Cohort Study of Physical Activity in Cardiovascular Outcomes (PACVO) in China: Objective, Design, and Baseline Characteristics.

miR-486 attenuates cardiac ischemia/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection.

Lymphangiogenesis contributes to exercise-induced physiological cardiac growth.

Editorial: Cardiovascular Fibrosis and Related Diseases: Basic and Clinical Research Advances.

PPARγ Mediates the Cardioprotective Roles of Danlou Tablet After Acute Myocardial Ischemia-Reperfusion Injury.

Downregulation of circ-ZNF609 Promotes Heart Repair by Modulating RNA N-Methyladenosine-Modified Expression.

Lymphatic regulation in tissue repair and regeneration: recent advance and future perspective.

DYRK1A: A promising protein kinase target for cardiomyocyte cycling and cardiac repair through epigenetic modifications.

Exercise training maintains cardiovascular health: signaling pathways involved and potential therapeutics.

A Versatile Design-Enabled Analysis of Circulating Extracellular Vesicles in Disease Diagnosis.

A modified apical resection model with high accuracy and reproducibility in neonatal mouse and rat hearts.